Arkolith/Insider Trading/GRNA/Form 4

Walker Matthew Alan

Director, 10% OwnerGreenLight Biosciences Holdings, PBC (GRNA) · full profile →Form 4 · filed Feb 4, 2022
Net Buying
Open-Market Buys
$15.0M
Open-Market Sells
$0
Net Open-Market Flow
$15.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2022Grant(A)14.3M——14.3M
Feb 2, 2022Buy(P)1.5M$10.00$15.0M15.8M

Transaction Codes

A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-22-002745) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML